Sophia N Karagiannis

Получаване на мой собствен потребителски профил

Позовавания

	Всички	От 2020
Позовавания	7980	5271
h-индекс	52	41
i10-индекс	117	106

1200

600

300

900

20082009201020112012201320142015201620172018201920202021202220232024202543 38 73 76 103 167 189 274 297 364 389 586 774 983 1113 1048 1105 241

Публичен достъп

Преглед на всички

135 статии

3 статии

налични

неналични

Въз основа на изисквания при финансирането

Съавтори

Debra Josephs MBChB, PhD, MRCPConsultant Medical OncologistПотвърден имейл адрес: kcl.ac.uk
Heather J BaxKing's College LondonПотвърден имейл адрес: kcl.ac.uk
Silvia CrescioliKing's College LondonПотвърден имейл адрес: kcl.ac.uk
Erika Jensen-JarolimComparative Medicine, Messerli Research Inst., Medical & Veterinary Universities Vienna, AustriaПотвърден имейл адрес: meduniwien.ac.at
Sophia TsokaKing's College LondonПотвърден имейл адрес: kcl.ac.uk
Philip Blowerking's college londonПотвърден имейл адрес: kcl.ac.uk
Judit Fazekas-SingerIST AustriaПотвърден имейл адрес: ist.ac.at
Mark HarriesConsultant Medical OncologistПотвърден имейл адрес: gstt.nhs.uk
Niwa AliUCSFПотвърден имейл адрес: ucsf.edu
Rodolfo BianchiniDept. of Comparative Medicine, Messerli Research Institute, University of Veterinary Medicine ViennaПотвърден имейл адрес: vetmeduni.ac.at
Alexander KoersImaging Sciences and Biomedical Engineering, Department of Chemistry/Biology, King's CollegeПотвърден имейл адрес: kcl.ac.uk
Jose Orgaz (ORCID 0000-0002-9776-...Instituto de Investigaciones Biomedicas Alberto Sols CSIC-UAMПотвърден имейл адрес: iib.uam.es
Chara Stavraka MD MRCP(UK) MRes...Medical OncologistПотвърден имейл адрес: kcl.ac.uk
James OpzoomerRelation TherapeuticsПотвърден имейл адрес: relationrx.com
Ania SkoweraAutoimmunity Group LeaderПотвърден имейл адрес: adaptimmune.com
Antonio SiccardiProfessor of Biology and Genetics, University of Milano and San Raffaele, MilanoПотвърден имейл адрес: hsr.it
Paola Di MeglioKing's College London, London,UKПотвърден имейл адрес: kcl.ac.uk
cedric gaggioliINSERM U1081, IRCANПотвърден имейл адрес: unice.fr
Robert KorngoldChairman, Department of Research, Hackensack University Medical CenterПотвърден имейл адрес: HackensackUMC.org
Louisa K JamesBlizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University ofПотвърден имейл адрес: qmul.ac.uk

Следене

Sophia N Karagiannis

Professor of Translational Cancer Immunology and Immunotherapy, King’s College London

Потвърден имейл адрес: kcl.ac.uk - Начална страница

B cell Immunology Cancer Immunology Cancer Antibody Discovery and Immunotherapy Humoral Responses in Cancer AllergoOncology


Заглавие Сортиране по цитати Сортиране по година Сортиране по заглавие	Позовавания Позовавания	Година
Targeting folate receptor alpha for cancer treatment A Cheung, HJ Bax, DH Josephs, KM Ilieva, G Pellizzari, J Opzoomer, ... Oncotarget 7 (32), 52553, 2016	478	2016
Resident CD141 (BDCA3)⁺ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation CC Chu, N Ali, P Karagiannis, P Di Meglio, A Skowera, L Napolitano, ... Journal of Experimental Medicine 209 (5), 935-945, 2012	318	2012
Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma DO Khair, HJ Bax, S Mele, S Crescioli, G Pellizzari, A Khiabany, ... Frontiers in immunology 10, 453, 2019	252	2019
AllergoOncology: the role of IgE‐mediated allergy in cancer E Jensen‐Jarolim, G Achatz, MC Turner, S Karagiannis, F Legrand, ... Allergy 63 (10), 1255-1266, 2008	249	2008
IgG4 subclass antibodies impair antitumor immunity in melanoma P Karagiannis, AE Gilbert, DH Josephs, N Ali, T Dodev, L Saul, I Correa, ... The Journal of Clinical Investigation 123 (4), 1457-1474, 2013	239	2013
Diverse matrix metalloproteinase functions regulate cancer amoeboid migration JL Orgaz, P Pandya, R Dalmeida, P Karagiannis, B Sanchez-Laorden, ... Nature communications 5 (1), 4255, 2014	218	2014
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs) RM Hoffmann, BGT Coumbe, DH Josephs, S Mele, KM Ilieva, A Cheung, ... Oncoimmunology 7 (3), e1395127, 2018	177	2018
An atlas of human regulatory T helper-like cells reveals features of Th2-like Tregs that support a tumorigenic environment L Halim, M Romano, R McGregor, I Correa, P Pavlidis, N Grageda, ... Cell reports 20 (3), 757-770, 2017	168	2017
Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment M Georgouli, C Herraiz, E Crosas-Molist, B Fanshawe, O Maiques, ... Cell 176 (4), 757-774. e23, 2019	166	2019
Comparison of IgE and IgG antibody‐dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma HJ Gould, GA Mackay, SN Karagiannis, CM O'Toole, PJ Marsh, BE Daniel, ... European journal of immunology 29 (11), 3527-3537, 1999	163	1999
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: treatment of melanoma and immune mechanisms of action ZN Willsmore, BGT Coumbe, S Crescioli, S Reci, A Gupta, RJ Harris, ... European Journal of Immunology 51 (3), 544-556, 2021	159	2021
IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells SN Karagiannis, MG Bracher, J Hunt, N McCloskey, RL Beavil, AJ Beavil, ... The Journal of Immunology 179 (5), 2832-2843, 2007	145	2007
Activity of human monocytes in IgE antibody‐dependent surveillance and killing of ovarian tumor cells SN Karagiannis, Q Wang, N East, F Burke, S Riffard, MG Bracher, ... European journal of immunology 33 (4), 1030-1040, 2003	141	2003
IgE antibodies: from structure to function and clinical translation BJ Sutton, AM Davies, HJ Bax, SN Karagiannis Antibodies 8 (1), 19, 2019	140	2019
Myosin II reactivation and cytoskeletal remodeling as a hallmark and a vulnerability in melanoma therapy resistance JL Orgaz, E Crosas-Molist, A Sadok, A Perdrix-Rosell, O Maiques, ... Cancer Cell 37 (1), 85-103. e9, 2020	138	2020
TGF-β-induced transcription sustains amoeboid melanoma migration and dissemination G Cantelli, JL Orgaz, I Rodriguez-Hernandez, P Karagiannis, O Maiques, ... Current biology 25 (22), 2899-2914, 2015	133	2015
Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells P Karagiannis, J Singer, J Hunt, SKE Gan, SM Rudman, ... Cancer immunology, immunotherapy 58, 915-930, 2009	127	2009
A tool kit for rapid cloning and expression of recombinant antibodies TS Dodev, P Karagiannis, AE Gilbert, DH Josephs, H Bowen, LK James, ... Scientific reports 4 (1), 5885, 2014	126	2014
IgG4 characteristics and functions in cancer immunity S Crescioli, I Correa, P Karagiannis, AM Davies, BJ Sutton, FO Nestle, ... Current allergy and asthma reports 16, 1-11, 2016	122	2016
Revisiting the role of B cells in skin immune surveillance IU Egbuniwe, SN Karagiannis, FO Nestle, KE Lacy Trends in immunology 36 (2), 102-111, 2015	120	2015

Системата не може да изпълни операцията сега. Опитайте отново по-късно.

Статии 1–20

Позовавания годишно

Дублирани описания

Обединени библиографски описания

Добавяне на съавториСъавтори

Следене

Позовавания

Съавтори